hers glp 1 injection Weight Loss Care for Women, Built to Last Hers and Hims Online GLP-1

News provided by Novo Nordisk Jul 01, 2026, 07:00 ET Starting today, eligible Medicare patients living with obesity can access Wegovy (semaglutide) injection and pill for a $50 monthly copay Wegovy offers adults living with obesity significant weight loss, along with diet and exercise, and is FDA-approved to lower the risk of major cardiovascular events including death, heart attack, or stroke in adults with obesity and heart disease a claim only Wegovy can make Since launching in January 2026, Wegovy pill has reached 3 million prescriptions * Medicare GLP-1 Bridge participation now expands patient access to authentic, FDA-approved Wegovy , including the Wegovy pill PLAINSBORO, N.J., July 1, 2026 /PRNewswire/ -- Starting today FDA-approved Wegovy (semaglutide) is available through the Medicare GLP-1 Bridge, a new access pathway for millions of older adults living with obesity

Molecular dynamics (MD) simulations: The structure of ER protein was constructed by Alphafold3

Pyruvate protects against kainate-induced epileptic brain damage in rats

Lower scores are better , thus the authors considered this data as potential evidence supporting slowing of disease progression

Vitamin B12 supports endurance through three mechanisms: red blood cell production that drives oxygen delivery, nervous system myelin synthesis, and converting carbohydrate and fat into ATP

For patients losing 20-50+ pounds: Plantar fasciitis risk drops by 35% Arthritis pain in weight-bearing joints improves Shoes fit better, reducing blisters and calluses 3